Literature DB >> 10963098

Abnormal somatosensory evoked potentials indicate compressive cervical myelopathy in mucopolysaccharidoses.

R Boor1, E Miebach, K Brühl, M Beck.   

Abstract

Compressive myelopathy at the cranio-cervical junction is a complication of mucopolysaccharidoses (MPS). To detect cervical myelopathy we recorded median and posterior tibial nerve SEPs in 15 patients aged 2.4-33.4 years (median 8.8 years) with MPS I-S (n = 3), MPS IVA (n = 8) and MPS VI (n = 4). In addition to the cortical waveforms we recorded the subcortical median nerve SEPs N13b and P13 generated near the cranio-cervical junction and the lemniscal P30 after posterior tibial nerve stimulation. MRI studies in 13 subjects revealed spinal cord compression at the cranio-cervical junction in 10 patients; 5 patients had an increased signal intensity on the T2-weighted initial MRI indicating high cervical myelomalacia and 4 patients had clinical signs of cervical myelopathy. We did not find a relationship between the SEPs and spinal cord compression. Abnormal SEPs were found in the patients with MRI evidence of myelomalacia (sensitivity 1.0, specificity 1.0) and correspondingly in the patients with clinical signs (sensitivity 1.0, specificity 0.91). The SEPs consequently deteriorated in 2 subjects of 7.3 and 10.3 years of age. Abnormal SEPs indicated subclinical cervical myelopathy in 3 subjects. Cervical cord compression may be present before occurrence of clinical or electrophysiological evidence of myelopathy. However, we feel that the SEP analysis is useful to detect functional impairment of the cervical cord in patients with MPS.

Entities:  

Mesh:

Year:  2000        PMID: 10963098     DOI: 10.1055/s-2000-7495

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  9 in total

1.  Outcomes from 18 years of cervical spine surgery in MPS IVA: a single centre's experience.

Authors:  A Broomfield; K Zuberi; J Mercer; G Moss; N Finnegan; P Hensman; R Walker; S Bukhari; N B Wright; F Stewart; S A Jones; R Ramirez
Journal:  Childs Nerv Syst       Date:  2018-06-26       Impact factor: 1.475

Review 2.  Mucopolysaccharidosis type I: current knowledge on its pathophysiological mechanisms.

Authors:  Derbis Campos; Madelyn Monaga
Journal:  Metab Brain Dis       Date:  2012-04-14       Impact factor: 3.584

3.  Development of a Scoring System to Evaluate the Severity of Craniocervical Spinal Cord Compression in Patients with Mucopolysaccharidosis IVA (Morquio A Syndrome).

Authors:  Christian Möllmann; Christian G Lampe; Wibke Müller-Forell; Maurizio Scarpa; Paul Harmatz; Manfred Schwarz; Michael Beck; Christina Lampe
Journal:  JIMD Rep       Date:  2013-04-12

4.  Craniocervical decompression in patients with mucopolysaccharidosis VI: development of a scoring system to determine indication and outcome of surgery.

Authors:  Christina Lampe; Christian Lampe; Manfred Schwarz; Wibke Müller-Forell; Paul Harmatz; Eugen Mengel
Journal:  J Inherit Metab Dis       Date:  2013-02-14       Impact factor: 4.982

5.  Safety of laronidase delivered into the spinal canal for treatment of cervical stenosis in mucopolysaccharidosis I.

Authors:  Patricia I Dickson; Ilkka Kaitila; Paul Harmatz; Anton Mlikotic; Agnes H Chen; Alla Victoroff; Merry B Passage; Jacqueline Madden; Steven Q Le; David E Naylor
Journal:  Mol Genet Metab       Date:  2015-07-26       Impact factor: 4.797

6.  Data from subjects receiving intrathecal laronidase for cervical spinal stenosis due to mucopolysaccharidosis type I.

Authors:  P I Dickson; I Kaitila; P Harmatz; A Mlikotic; A H Chen; A Victoroff; M B Passage; J Madden; S Q Le; D E Naylor
Journal:  Data Brief       Date:  2015-08-20

7.  Chiari I malformation and syringomyelia in mucopolysaccharidosis type I (Hurler syndrome) treated with posterior fossa decompression: Case report and review of the literature.

Authors:  Vyacheslav Makler; Christina L Goldstein; Daniel Hoernschemeyer; Tomoko Tanaka
Journal:  Surg Neurol Int       Date:  2017-05-26

8.  Adjunct Diagnostic Value of Transcranial Magnetic Stimulation in Mucopolysaccharidosis-Related Cervical Myelopathy: A Pilot Study.

Authors:  Mariagiovanna Cantone; Giuseppe Lanza; Alice Le Pira; Rita Barone; Giovanni Pennisi; Rita Bella; Manuela Pennisi; Agata Fiumara
Journal:  Brain Sci       Date:  2019-08-14

Review 9.  Spinal involvement in mucopolysaccharidosis IVA (Morquio-Brailsford or Morquio A syndrome): presentation, diagnosis and management.

Authors:  Guirish A Solanki; Kenneth W Martin; Mary C Theroux; Christina Lampe; Klane K White; Renée Shediac; Christian G Lampe; Michael Beck; William G Mackenzie; Christian J Hendriksz; Paul R Harmatz
Journal:  J Inherit Metab Dis       Date:  2013-02-06       Impact factor: 4.982

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.